Skip to main content
  • AACR Publications
    • Blood Cancer Discovery
    • Cancer Discovery
    • Cancer Epidemiology, Biomarkers & Prevention
    • Cancer Immunology Research
    • Cancer Prevention Research
    • Cancer Research
    • Clinical Cancer Research
    • Molecular Cancer Research
    • Molecular Cancer Therapeutics

AACR logo

  • Register
  • Log in
  • Log out
  • My Cart
Advertisement

Main menu

  • Home
  • About
    • The Journal
    • AACR Journals
    • Subscriptions
    • Permissions and Reprints
  • Articles
    • OnlineFirst
    • Current Issue
    • Past Issues
    • CEBP Focus Archive
    • Meeting Abstracts
    • Progress and Priorities
    • Collections
      • COVID-19 & Cancer Resource Center
      • Disparities Collection
      • Editors' Picks
      • "Best of" Collection
  • For Authors
    • Information for Authors
    • Author Services
    • Best of: Author Profiles
    • Informing Public Health Policy
    • Submit
  • Alerts
    • Table of Contents
    • Editors' Picks
    • OnlineFirst
    • Citation
    • Author/Keyword
    • RSS Feeds
    • My Alert Summary & Preferences
  • News
    • Cancer Discovery News
  • COVID-19
  • Webinars
  • Search More

    Advanced Search

  • AACR Publications
    • Blood Cancer Discovery
    • Cancer Discovery
    • Cancer Epidemiology, Biomarkers & Prevention
    • Cancer Immunology Research
    • Cancer Prevention Research
    • Cancer Research
    • Clinical Cancer Research
    • Molecular Cancer Research
    • Molecular Cancer Therapeutics

User menu

  • Register
  • Log in
  • Log out
  • My Cart

Search

  • Advanced search
Cancer Epidemiology, Biomarkers & Prevention
Cancer Epidemiology, Biomarkers & Prevention
  • Home
  • About
    • The Journal
    • AACR Journals
    • Subscriptions
    • Permissions and Reprints
  • Articles
    • OnlineFirst
    • Current Issue
    • Past Issues
    • CEBP Focus Archive
    • Meeting Abstracts
    • Progress and Priorities
    • Collections
      • COVID-19 & Cancer Resource Center
      • Disparities Collection
      • Editors' Picks
      • "Best of" Collection
  • For Authors
    • Information for Authors
    • Author Services
    • Best of: Author Profiles
    • Informing Public Health Policy
    • Submit
  • Alerts
    • Table of Contents
    • Editors' Picks
    • OnlineFirst
    • Citation
    • Author/Keyword
    • RSS Feeds
    • My Alert Summary & Preferences
  • News
    • Cancer Discovery News
  • COVID-19
  • Webinars
  • Search More

    Advanced Search

Null Results in Brief

Common Obesity-Related Genetic Variants and Papillary Thyroid Cancer Risk

Cari M. Kitahara, Gila Neta, Ruth M. Pfeiffer, Deukwoo Kwon, Li Xu, Neal D. Freedman, Amy A. Hutchinson, Stephen J. Chanock, Erich M. Sturgis, Alice J. Sigurdson and Alina V. Brenner
Cari M. Kitahara
1Division of Cancer Epidemiology and Genetics, National Cancer Institute, NIH, Rockville; 2Core Genotyping Facility, SAIC-Frederick Inc., National Cancer Institute-Frederick, Frederick, Maryland; 3Biostatistics and Bioinformatics Core, Sylvester Comprehensive Cancer Center, University of Miami, Miami, Florida; and 4Department of Head and Neck Surgery, the University of Texas MD Anderson Cancer Center, Houston, Texas
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Gila Neta
1Division of Cancer Epidemiology and Genetics, National Cancer Institute, NIH, Rockville; 2Core Genotyping Facility, SAIC-Frederick Inc., National Cancer Institute-Frederick, Frederick, Maryland; 3Biostatistics and Bioinformatics Core, Sylvester Comprehensive Cancer Center, University of Miami, Miami, Florida; and 4Department of Head and Neck Surgery, the University of Texas MD Anderson Cancer Center, Houston, Texas
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Ruth M. Pfeiffer
1Division of Cancer Epidemiology and Genetics, National Cancer Institute, NIH, Rockville; 2Core Genotyping Facility, SAIC-Frederick Inc., National Cancer Institute-Frederick, Frederick, Maryland; 3Biostatistics and Bioinformatics Core, Sylvester Comprehensive Cancer Center, University of Miami, Miami, Florida; and 4Department of Head and Neck Surgery, the University of Texas MD Anderson Cancer Center, Houston, Texas
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Deukwoo Kwon
1Division of Cancer Epidemiology and Genetics, National Cancer Institute, NIH, Rockville; 2Core Genotyping Facility, SAIC-Frederick Inc., National Cancer Institute-Frederick, Frederick, Maryland; 3Biostatistics and Bioinformatics Core, Sylvester Comprehensive Cancer Center, University of Miami, Miami, Florida; and 4Department of Head and Neck Surgery, the University of Texas MD Anderson Cancer Center, Houston, Texas
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Li Xu
1Division of Cancer Epidemiology and Genetics, National Cancer Institute, NIH, Rockville; 2Core Genotyping Facility, SAIC-Frederick Inc., National Cancer Institute-Frederick, Frederick, Maryland; 3Biostatistics and Bioinformatics Core, Sylvester Comprehensive Cancer Center, University of Miami, Miami, Florida; and 4Department of Head and Neck Surgery, the University of Texas MD Anderson Cancer Center, Houston, Texas
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Neal D. Freedman
1Division of Cancer Epidemiology and Genetics, National Cancer Institute, NIH, Rockville; 2Core Genotyping Facility, SAIC-Frederick Inc., National Cancer Institute-Frederick, Frederick, Maryland; 3Biostatistics and Bioinformatics Core, Sylvester Comprehensive Cancer Center, University of Miami, Miami, Florida; and 4Department of Head and Neck Surgery, the University of Texas MD Anderson Cancer Center, Houston, Texas
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Amy A. Hutchinson
1Division of Cancer Epidemiology and Genetics, National Cancer Institute, NIH, Rockville; 2Core Genotyping Facility, SAIC-Frederick Inc., National Cancer Institute-Frederick, Frederick, Maryland; 3Biostatistics and Bioinformatics Core, Sylvester Comprehensive Cancer Center, University of Miami, Miami, Florida; and 4Department of Head and Neck Surgery, the University of Texas MD Anderson Cancer Center, Houston, Texas
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Stephen J. Chanock
1Division of Cancer Epidemiology and Genetics, National Cancer Institute, NIH, Rockville; 2Core Genotyping Facility, SAIC-Frederick Inc., National Cancer Institute-Frederick, Frederick, Maryland; 3Biostatistics and Bioinformatics Core, Sylvester Comprehensive Cancer Center, University of Miami, Miami, Florida; and 4Department of Head and Neck Surgery, the University of Texas MD Anderson Cancer Center, Houston, Texas
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Erich M. Sturgis
1Division of Cancer Epidemiology and Genetics, National Cancer Institute, NIH, Rockville; 2Core Genotyping Facility, SAIC-Frederick Inc., National Cancer Institute-Frederick, Frederick, Maryland; 3Biostatistics and Bioinformatics Core, Sylvester Comprehensive Cancer Center, University of Miami, Miami, Florida; and 4Department of Head and Neck Surgery, the University of Texas MD Anderson Cancer Center, Houston, Texas
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Alice J. Sigurdson
1Division of Cancer Epidemiology and Genetics, National Cancer Institute, NIH, Rockville; 2Core Genotyping Facility, SAIC-Frederick Inc., National Cancer Institute-Frederick, Frederick, Maryland; 3Biostatistics and Bioinformatics Core, Sylvester Comprehensive Cancer Center, University of Miami, Miami, Florida; and 4Department of Head and Neck Surgery, the University of Texas MD Anderson Cancer Center, Houston, Texas
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Alina V. Brenner
1Division of Cancer Epidemiology and Genetics, National Cancer Institute, NIH, Rockville; 2Core Genotyping Facility, SAIC-Frederick Inc., National Cancer Institute-Frederick, Frederick, Maryland; 3Biostatistics and Bioinformatics Core, Sylvester Comprehensive Cancer Center, University of Miami, Miami, Florida; and 4Department of Head and Neck Surgery, the University of Texas MD Anderson Cancer Center, Houston, Texas
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
DOI: 10.1158/1055-9965.EPI-12-0790 Published December 2012
  • Article
  • Figures & Data
  • Info & Metrics
  • PDF
Loading

Abstract

Background: Epidemiologic studies have shown consistent associations between obesity and increased thyroid cancer risk, but, to date, no studies have investigated the relationship between thyroid cancer risk and obesity-related single-nucleotide polymorphisms (SNP).

Methods: We evaluated 575 tag SNPs in 23 obesity-related gene regions in a case–control study of 341 incident papillary thyroid cancer (PTC) cases and 444 controls of European ancestry. Logistic regression models, adjusted for attained age, year of birth, and sex were used to calculate ORs and 95% confidence intervals (CI) with SNP genotypes, coded as 0, 1, and 2 and modeled continuously to calculate Ptrend.

Results: Nine of 10 top-ranking SNPs (Ptrend < 0.01) were located in the FTO (fat mass and obesity associated) gene region, whereas the other was located in INSR (insulin receptor). None of the associations were significant after correcting for multiple testing.

Conclusions: Our data do not support an important role of obesity-related genetic polymorphisms in determining the risk of PTC.

Impact: Factors other than selected genetic polymorphisms may be responsible for the observed associations between obesity and increased PTC risk. Cancer Epidemiol Biomarkers Prev; 21(12); 2268–71. ©2012 AACR.

Introduction

Obesity has consistently been associated with increased risk of thyroid cancer in epidemiologic studies (1), but the biologic mechanisms underlying this association remain poorly understood. Evaluating genetic variation in obesity-related genes may help to identify pathways involved in thyroid cancer etiology, independent of, or mediated by, body size.

We examined associations between single-nucleotide polymorphisms (SNP) in 23 obesity-related candidate genes and papillary thyroid cancer (PTC), the most common histologic type of thyroid cancer. These genes were chosen because of their role in body energy homeostasis and metabolism or previous associations with obesity or type II diabetes (2–5).

Materials and Methods

The study population has been previously described (6). In brief, cases included individuals diagnosed with incident, histologically confirmed PTC during follow-up of the U.S. Radiologic Technologists (USRT) cohort (n = 202), and individuals diagnosed and treated for PTC at the University of Texas MD Anderson Cancer Center (UTMDACC; Houston, TX; n = 142). In USRT, controls (n = 452) were frequency matched by race, year of birth (±2 years), and sex to cases. Controls from USRT were then selected to match cases from UTMDACC. Analyses were restricted to non-Hispanic whites. Three cases and 8 controls were excluded because of missing height or weight. The Institutional Review Boards approved the use of these data, and all subjects provided written informed consent.

The 23 genes chosen for this analysis (listed in Supplementary Table S1) were selected a priori. Tag SNPs (n = 575) were selected from the common SNPs (minor allele frequency >5%) genotyped by the HapMap Project in the Caucasian population using TagZilla, part of the GLU software package, with a binning threshold of r2 > 0.8. Genotyping was carried out at the National Cancer Institute (NCI) Core Genotyping Facility using a custom-designed iSelect Infinium assay. SNPs were excluded if they failed quality-control measures: less than 95% concordance, less than 90% completion, or had evidence of a departure from Hardy–Weinberg equilibrium in controls (P < 0.00001). Allele frequencies were largely similar between USRT and UTMDACC cases; thus, these groups were combined for analyses.

Data on demographics, medical history, anthropometry, and other health-related characteristics were collected by self-administered questionnaires or telephone interview in USRT and self-administered questionnaire at time of blood collection in UTMDACC.

We computed SNP-specific Ptrend and ORs and 95% confidence intervals (CI) for each genotype, using logistic regression models adjusted for sex, attained age, and year of birth. Separate models additionally adjusted for body mass index (BMI). We also examined 138,605 2-way SNP–SNP interactions using allelic-based gene–gene interactions in models adjusted for sex, attained age, year of birth, and BMI (7). We combined SNP-specific Ptrend into region-based P values using the adaptive rank–truncated method (8). P values less than 0.05 were considered statistically significant, and tests were 2-sided. While tables show uncorrected P values, we also conducted correction for multiple comparisons controlling the false discovery rate (FDR). Statistical analyses were conducted using Stata/SE version 11.0 and R software.

Results

Compared with controls, PTC cases were more likely to have a family history of thyroid cancer among first-degree relatives and less likely to be current smokers (Table 1). Cases had higher BMI as compared with controls.

View this table:
  • View inline
  • View popup
Table 1.

Select characteristics of the cases and controls

Of the 10 SNPs identified with the lowest SNP-level P values (Table 2), 9 were located in FTO (fat mass and obesity associated) and 1 was located in INSR (insulin receptor). However, none remained statistically significant after FDR correction. Although BMI was associated with increased PTC risk (per 5 kg/m2, OR = 1.18, 95% CI: 1.02–1.37), additional adjustment for BMI did not appreciably change the SNP–PTC associations. We did not observe statistically significant SNP–SNP interactions after FDR correction. Also, at gene region level none was significantly associated with PTC risk (all region-based P values >0.2).

View this table:
  • View inline
  • View popup
Table 2.

Associations between obesity-related SNPs and papillary thyroid cancer risk

Discussion

In general, our results do not suggest an important role of selected obesity-related genetic variants in determining PTC risk. Certain polymorphisms in the FTO and INSR genes were weakly linked to PTC risk independent of BMI, but these associations were no longer significant after multiple comparisons correction.

Genes chosen for this analysis were a priori selected on the basis of their known functions or observed associations with obesity, thereby reducing the possibility that our findings were due solely to chance. Nonetheless, there may be other obesity-related genes that were not considered in our genotyping platform but may play an important role in papillary thyroid carcinogenesis. More agnostic approaches may be needed to discover important genetic risk factors for this disease. In addition, while most individual SNPs and none of the 2-way interactions were not significantly associated with PTC risk, certain combination of SNPs may have stronger effects, although larger studies are necessary to detect SNP–SNP interactions.

As the biologic mechanisms underlying the observed obesity-thyroid cancer relationship remain unclear, the results of this study underscore the need to evaluate, directly, levels of various adipocytokines and other obesity-related biomarkers, as well as modifiable determinants of obesity, including over-nutrition and physical inactivity, as possible risk factors for this disease.

Disclosure of Potential Conflicts of Interest

No potential conflicts of interest were disclosed. The content of this publication does not necessarily reflect the views or policies of the Department of Health and Human Services, nor does mention of trade names, commercial products, or organizations imply endorsement by the U.S. Government.

Authors' Contributions

Conception and design: C.M. Kitahara, G. Neta, R.M. Pfeiffer, N.D. Freedman, E.M. Sturgis, A.J. Sigurdson, A.V. Brenner

Development of methodology: R.M. Pfeiffer, A.V. Brenner

Acquisition of data (provided animals, acquired and managed patients, provided facilities, etc.): A.A. Hutchinson, A.J. Sigurdson

Analysis and interpretation of data (e.g., statistical analysis, biostatistics, computational analysis): C.M. Kitahara, R.M. Pfeiffer, D. Kwon, N.D. Freedman, A.J. Sigurdson, A.V. Brenner

Writing, review, and/or revision of the manuscript: C.M. Kitahara, G. Neta, R.M. Pfeiffer, L. Xu, N.D. Freedman, S.J. Chanock, E.M. Sturgis, A.J. Sigurdson, A.V. Brenner

Administrative, technical, or material support (i.e., reporting or organizing data, constructing databases): G. Neta, L. Xu, E.M. Sturgis, A.J. Sigurdson, A.V. Brenner

Study supervision: A.J. Sigurdson, A.V. Brenner

Material support and database: E.M. Sturgis

Grant Support

This research was supported in part by the Intramural Research Program of the NCI, NIH. This project has been funded in whole or in part with federal funds from the NCI, NIH, under contract no. HHSN261200800001E.

Footnotes

  • Note: Supplementary data for this article are available at Cancer Epidemiology, Biomarkers & Prevention Online (http://cebp.aacrjournals.org/).

  • Received July 3, 2012.
  • Revision received September 6, 2012.
  • Accepted October 1, 2012.
  • ©2012 American Association for Cancer Research.

References

  1. 1.↵
    1. Renehan AG,
    2. Tyson M,
    3. Egger M,
    4. Heller RF,
    5. Zwahlen M
    . Body-mass index and incidence of cancer: a systematic review and meta-analysis of prospective observational studies. Lancet 2008;371:569–78.
    OpenUrlCrossRefPubMed
  2. 2.↵
    1. Enns JE,
    2. Taylor CG,
    3. Zahradka P
    . Variations in adipokine genes AdipoQ, Lep, and LepR are associated with risk for obesity-related metabolic disease: the modulatory role of gene-nutrient interactions. J Obesity 2011;2011:168659.
    OpenUrl
  3. 3.↵
    1. Herbert A,
    2. Gerry NP,
    3. McQueen MB,
    4. Heid IM,
    5. Pfeufer A,
    6. Illig T,
    7. et al.
    A common genetic variant is associated with adult and childhood obesity. Science 2006;312:279–83.
    OpenUrlAbstract/FREE Full Text
  4. 4.↵
    1. Speliotes EK,
    2. Willer CJ,
    3. Berndt SI,
    4. Monda KL,
    5. Thorliefsson G,
    6. Jackson AU,
    7. et al.
    Association analyses of 249,796 individuals reveal 18 new loci associated with body mass index. Nat Genet 2010;42:937–48.
    OpenUrlCrossRefPubMed
  5. 5.↵
    1. Billings LK,
    2. Florez JC
    . The genetics of type 2 diabetes: what have we learned from GWAS? Ann N Y Acad Sci 2010;1212:59–77.
    OpenUrlCrossRefPubMed
  6. 6.↵
    1. Neta G,
    2. Brenner AV,
    3. Sturgis EM,
    4. Pfeiffer RM,
    5. Hutchinson AA,
    6. Aschebrook-Kilfoy B,
    7. et al.
    Common genetic variants related to genomic integrity and risk of papillary thyroid cancer. Carcinogenesis 2011;32:1231–7.
    OpenUrlAbstract/FREE Full Text
  7. 7.↵
    1. Jung J,
    2. Song JJ,
    3. Kwon D
    . Allelic based gene–gene interactions in rheumatoid arthritis. BMC Proc 2009;3(Suppl. 7):S76.
    OpenUrlPubMed
  8. 8.↵
    1. Yu K,
    2. Li Q,
    3. Bergen AW,
    4. Pfeiffer RM,
    5. Rosenberg PS,
    6. Caporaso N,
    7. et al.
    Pathway analysis by adaptive combination of P-values. Genet Epidemiol 2009;33:700–9.
    OpenUrlCrossRefPubMed
PreviousNext
Back to top
Cancer Epidemiology Biomarkers & Prevention: 21 (12)
December 2012
Volume 21, Issue 12
  • Table of Contents
  • Table of Contents (PDF)

Sign up for alerts

View this article with LENS

Open full page PDF
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for sharing this Cancer Epidemiology, Biomarkers & Prevention article.

NOTE: We request your email address only to inform the recipient that it was you who recommended this article, and that it is not junk mail. We do not retain these email addresses.

Enter multiple addresses on separate lines or separate them with commas.
Common Obesity-Related Genetic Variants and Papillary Thyroid Cancer Risk
(Your Name) has forwarded a page to you from Cancer Epidemiology, Biomarkers & Prevention
(Your Name) thought you would be interested in this article in Cancer Epidemiology, Biomarkers & Prevention.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Citation Tools
Common Obesity-Related Genetic Variants and Papillary Thyroid Cancer Risk
Cari M. Kitahara, Gila Neta, Ruth M. Pfeiffer, Deukwoo Kwon, Li Xu, Neal D. Freedman, Amy A. Hutchinson, Stephen J. Chanock, Erich M. Sturgis, Alice J. Sigurdson and Alina V. Brenner
Cancer Epidemiol Biomarkers Prev December 1 2012 (21) (12) 2268-2271; DOI: 10.1158/1055-9965.EPI-12-0790

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Share
Common Obesity-Related Genetic Variants and Papillary Thyroid Cancer Risk
Cari M. Kitahara, Gila Neta, Ruth M. Pfeiffer, Deukwoo Kwon, Li Xu, Neal D. Freedman, Amy A. Hutchinson, Stephen J. Chanock, Erich M. Sturgis, Alice J. Sigurdson and Alina V. Brenner
Cancer Epidemiol Biomarkers Prev December 1 2012 (21) (12) 2268-2271; DOI: 10.1158/1055-9965.EPI-12-0790
del.icio.us logo Digg logo Reddit logo Twitter logo CiteULike logo Facebook logo Google logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Jump to section

  • Article
    • Abstract
    • Introduction
    • Materials and Methods
    • Results
    • Discussion
    • Disclosure of Potential Conflicts of Interest
    • Authors' Contributions
    • Grant Support
    • Footnotes
    • References
  • Figures & Data
  • Info & Metrics
  • PDF
Advertisement

Related Articles

Cited By...

More in this TOC Section

  • Soft drink and juice consumption and renal cell carcinoma
  • Associations of ACEi and ARB with CRC Risk
  • Telomere length and TGCT risk
Show more Null Results in Brief
  • Home
  • Alerts
  • Feedback
  • Privacy Policy
Facebook   Twitter   LinkedIn   YouTube   RSS

Articles

  • Online First
  • Current Issue
  • Past Issues

Info for

  • Authors
  • Subscribers
  • Advertisers
  • Librarians

About Cancer Epidemiology, Biomarkers & Prevention

  • About the Journal
  • Editorial Board
  • Permissions
  • Submit a Manuscript
AACR logo

Copyright © 2021 by the American Association for Cancer Research.

Cancer Epidemiology, Biomarkers & Prevention
eISSN: 1538-7755
ISSN: 1055-9965

Advertisement